本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

9.78
-0.5100-4.96%
盤後9.920.1400+1.43%19:30 EDT
成交量:173.33萬
成交額:1,710.57萬
市值:8.52億
市盈率:-4.59
高:10.34
開:10.29
低:9.65
收:10.29
52周最高:36.26
52周最低:6.65
股本:8,715.70萬
流通股本:7,188.81萬
量比:1.56
換手率:2.41%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
淨資產收益率:-52.74%
總資產收益率:-31.82%
市淨率:1.98
市盈率(LYR):-5.23

資料載入中...

2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/23

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/29

重要事件披露

Form 8-K - Current report
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/16

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]